Search Results

8326 - 8350 of 89764
TitleWireDateTime
Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth Globe Newswire 09/23 08:00
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company Globe Newswire 09/23 08:00
Nano Dimension Acquisition of Desktop Metal Receives Support from Leading Proxy Advisory Firm - ISS Globe Newswire 09/23 08:00
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference Globe Newswire 09/23 08:00
Actuate Announces Scientific Reports Publication on Elraglusib’s Novel Immunomodulatory Mechanism of Action as a GSK-3β Inhibitor Globe Newswire 09/23 08:00
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Globe Newswire 09/23 08:00
Vortex Energy Retrieves 279 Meters Of Core Containing Visible Salt Mineralization From The Robinsons River Salt Project Globe Newswire 09/23 08:00
Hearing Aid Market to Witness 6.30% CAGR by 2031 | SkyQuest Technology Globe Newswire 09/23 08:00
Xunlei Announces Appointment of Two New Directors Globe Newswire 09/23 08:00
Applied Digital Sets Fiscal First Quarter 2025 Earnings Conference Call for Wednesday, October 9, 2024 at 5:00 p.m. Eastern Time Globe Newswire 09/23 08:00
The Oncology Institute Announces CFO Transition Globe Newswire 09/23 08:00
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi Globe Newswire 09/23 08:00
Provident Bank Welcomes Vivin Varghese As Senior Vice President, Chief Information Security Officer Globe Newswire 09/23 08:00
ARS Pharmaceuticals Announces U.S. Availability of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis Globe Newswire 09/23 08:00
LifeSci Advisors Appoints Lindsey Trickett to its Investor Relations Team Globe Newswire 09/23 08:00
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis Globe Newswire 09/23 08:00
Integer Completes Two Irish Facility Expansions to Support Growth, Strengthen Capabilities in Critical Medtech Region Globe Newswire 09/23 08:00
Kratos SRE Welcomes Congressman Gary Palmer to Facility in Birmingham Globe Newswire 09/23 08:00
Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor) Globe Newswire 09/23 08:00
Crypto Proprietary Trading Firm HyroTrader Experiences Rapid Growth Globe Newswire 09/23 07:59
ProStar Announces that a Global Fortune 500 Energy Company Adopts PointMan to Improve Refinery Maintenance Operations Globe Newswire 09/23 07:58
Three Protocol Introduces Fraud-Resistant eCommerce Solutions, Pioneering Crypto as the Future of Payment Globe Newswire 09/23 07:56
Sports.com Expands Geographical Footprint, Launching in New Markets Across Asia Globe Newswire 09/23 07:53
Luzhou Hosted The 3rd Global Geographical Indications Products Expo Globe Newswire 09/23 07:52
Brookfield Global Infrastructure Securities Income Fund Announces Quarterly Distribution Globe Newswire 09/23 07:50
8326 - 8350 of 89764

News, Photo and Web Search

Search News by Ticker